Si-Bone
SIBN
18.68
-0.42
-2.20%
Si-Bone
US · SIBN
#3357 by market cap
Listed 2018
18.68
-0.42
-2.20%
Live - 5344 symbols - heartbeat 465s ago
· 2026-10-08 10:10
Pre-market
19.10
0.00%
After-hours
19.10
0.00%
- Market cap
- 837.21M
- P/E (TTM)i
- -56.61
- P/Bi
- 4.59
- EPSi
- -0.44
- Div yieldi
- 0.00%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on SIBN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.08, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +20.19% YoY
Margins
- Gross margin
- 79.57%
- Operating margin
- -11.11%
- Net margin
- -9.41%
Key ratios & quality
- Enterprise valuei
- 725.90M
- Altman Z-Scorei
- 7.08
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 55.38M | 67.30M | 73.39M | 90.15M | 106.41M | 138.89M | 167.18M | 200.93M |
| Gross profit | 50.55M | 60.51M | 64.49M | 79.72M | 90.70M | 109.42M | 132.12M | 159.88M |
| Selling & admin expenses | 57.14M | 89.24M | 93.59M | 118.95M | 136.69M | 141.32M | 150.81M | 164.76M |
| Research & development | 5.38M | 7.28M | 9.46M | 12.44M | 13.63M | 15.03M | 16.56M | 17.45M |
| Operating profit | -11.97M | -36.00M | -38.57M | -51.67M | -59.61M | -46.93M | -35.25M | -22.33M |
| Pretax profit | -17.45M | -38.40M | -43.70M | -56.57M | -61.26M | -43.34M | -30.91M | -18.90M |
| Tax | -- | -- | -- | -- | -- | -- | -- | -- |
| Net profit | -17.45M | -38.40M | -43.70M | -56.57M | -61.26M | -43.34M | -30.91M | -18.90M |
| Basic EPS | -2 | -2 | -2 | -2 | -2 | -1 | -1 | 0 |
| Diluted EPS | -2.20 | -1.55 | -1.50 | -1.71 | -1.79 | -1.13 | -0.75 | -0.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 47.29M | 48.63M | 48.66M | 56.35M | 52.59M | 56.01M |
| Gross profit | 37.70M | 38.81M | 38.85M | 44.53M | 41.94M | 44.55M |
| Selling & admin expenses | 40.64M | 41.50M | 39.99M | 42.63M | 42.85M | 44.13M |
| Research & development | 4.53M | 4.31M | 4.24M | 4.36M | 4.19M | 5.22M |
| Operating profit | -7.48M | -7.00M | -5.38M | -2.46M | -5.09M | -4.81M |
| Pretax profit | -6.54M | -6.15M | -4.57M | -1.64M | -4.33M | -4.09M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -6.54M | -6.15M | -4.57M | -1.64M | -4.33M | -4.09M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.15 | -0.14 | -0.11 | -0.04 | -0.10 | -0.09 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 136.04M | 111.46M | 218.24M | 175.87M | 137.61M | 211.39M | 207.78M | 216.12M |
| Cash & ST investments | 122.22M | 91.78M | 196.43M | 146.98M | 97.29M | 166.02M | 150.04M | 147.82M |
| Inventory | 3.34M | 5.45M | 5.63M | 11.50M | 17.28M | 20.25M | 27.07M | 33.90M |
| Total assets | 138.52M | 117.01M | 223.14M | 190.51M | 157.55M | 230.43M | 230.44M | 238.56M |
| Total current liabilities | 9.01M | 18.77M | 13.47M | 16.89M | 21.18M | 23.46M | 27.13M | 25.28M |
| Short-term debt | -- | 4.36M | -- | 1.34M | 1.39M | 1.42M | 1.15M | 944.00K |
| Long-term debt | 38.96M | 34.87M | 39.46M | 34.97M | 35.17M | 36.07M | 35.45M | 35.57M |
| Total liabilities | 48,329,000.00 | 54,001,000.00 | 53,779,000.00 | 56,086,000.00 | 59,250,000.00 | 61,050,000.00 | 63,473,000.00 | 61,023,000.00 |
| Total equity | 90.19M | 63.01M | 169.36M | 134.42M | 98.30M | 169.38M | 166.96M | 177.53M |
| Retained earnings | -157.18M | -195.58M | -239.28M | -295.85M | -357.11M | -400.44M | -431.35M | -450.26M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 204.20M | 207.45M | 210.78M | 216.12M | 214.72M | 219.91M |
| Cash & ST investments | 144.41M | 145.54M | 145.74M | 147.82M | 144.68M | 145.94M |
| Inventory | 30.38M | 34.25M | 35.73M | 33.90M | 35.53M | 38.39M |
| Total assets | 227.28M | 230.92M | 234.27M | 238.56M | 242.72M | 248.76M |
| Total current liabilities | 23.95M | 24.75M | 26.44M | 25.28M | 21.49M | 24.04M |
| Short-term debt | 1.09M | 1.11M | 1.13M | 944.00K | 658.00K | 426.00K |
| Long-term debt | 35.48M | 35.51M | 35.54M | 35.57M | 35.60M | 35.63M |
| Total liabilities | 60,016,000.00 | 60,578,000.00 | 62,147,000.00 | 61,023,000.00 | 63,776,000.00 | 66,411,000.00 |
| Total equity | 167.26M | 170.34M | 172.13M | 177.53M | 178.94M | 182.35M |
| Retained earnings | -437.90M | -444.05M | -448.61M | -450.26M | -454.59M | -458.68M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -14.52M | -31.63M | -30.66M | -39.53M | -41.66M | -18.71M | -12.43M | -675.00K |
| Depreciation & amortization | 722.00K | 774.00K | 1.13M | 2.09M | 3.45M | 5.43M | 4.38M | 5.77M |
| Free cash flow | -15.46M | -34.07M | -33.22M | -45.92M | -51.16M | -26.51M | -22.92M | -9.09M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 115.51M | 0 | 134.62M | -- | 0 | 83.67M | 0 | 0 |
| Ending cash balance | 25.12M | 10.44M | 53.58M | 63.42M | 20.72M | 33.27M | 34.95M | 42.24M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -4.91M | 173.00K | 2.34M | 1.73M | -2.36M | 777.00K |
| Depreciation & amortization | 1.28M | 1.37M | 1.49M | 1.64M | 1.62M | 1.68M |
| Free cash flow | -6.98M | -1.93M | -620.00K | 440.00K | -3.44M | -768.00K |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 41.19M | 34.15M | 26.49M | 42.24M | 33.54M | 33.13M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -50.13 | -37.61 | -37.25 | -52.64 | -32.38 | -18.38 | -10.97 |
| ROA %i | -20.02 | -30.06 | -25.69 | -27.35 | -35.20 | -22.34 | -13.42 | -8.06 |
| ROIC %i | -- | -30.55 | -25.23 | -26.69 | -38.22 | -27.04 | -17.11 | -10.68 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -42.00 | -35.65 | -30.32 |
| EBIT margin %i | -22.29 | -49.71 | -51.23 | -56.80 | -54.92 | -28.71 | -16.43 | -8.10 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 15.11 | 5.94 | 16.20 | 10.41 | 6.50 | 9.01 | 7.66 | 8.55 |
| Quick ratioi | 14.51 | 5.51 | 15.59 | 9.55 | 5.57 | 8.01 | 6.54 | 7.03 |
| Debt / assetsi | 28.13 | 33.52 | 17.68 | 21.25 | 25.03 | 16.92 | 16.27 | 15.38 |
| LT debt / equityi | 43.20 | 55.33 | 23.30 | 29.12 | 38.70 | 22.19 | 21.76 | 20.13 |
| Interest coveragei | -2.42 | -6.76 | -6.16 | -9.54 | -20.73 | -11.52 | -7.99 | -6.19 |
| Revenue CAGR (3Y) %i | -- | 16.93 | 15.22 | 17.64 | 16.50 | 23.69 | 22.86 | 23.60 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -15.96 | -14.18 | -12.91 | -10.97 | -9.65 | -8.30 |
| ROA %i | -11.77 | -10.45 | -9.43 | -8.06 | -7.10 | -6.10 |
| ROIC %i | -15.00 | -13.44 | -12.30 | -10.68 | -9.37 | -8.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -13.21 | -11.20 | -9.80 | -8.10 | -6.86 | -5.68 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 8.53 | 8.38 | 7.97 | 8.55 | 9.99 | 9.15 |
| Quick ratioi | 7.14 | 6.87 | 6.52 | 7.03 | 8.20 | 7.37 |
| Debt / assetsi | 16.35 | 15.99 | 15.72 | 15.38 | 17.69 | 17.20 |
| LT debt / equityi | 21.56 | 21.03 | 20.74 | 20.13 | 23.63 | 23.24 |
| Interest coveragei | -7.24 | -6.90 | -6.79 | -6.19 | -5.53 | -4.88 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 10:10:53 · For reference only, not investment advice and not tailored to your situation.